These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18095874)

  • 1. Cloning, expression and characterization of insulin-degrading enzyme from tomato (Solanum lycopersicum).
    Huet Y; Strassner J; Schaller A
    Biol Chem; 2008 Jan; 389(1):91-8. PubMed ID: 18095874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning, expression, and characterization of tomato (Lycopersicon esculentum) aminopeptidase P.
    Hauser F; Strassner J; Schaller A
    J Biol Chem; 2001 Aug; 276(34):31732-7. PubMed ID: 11423553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
    Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
    J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
    Ciaccio C; Tundo GR; Grasso G; Spoto G; Marasco D; Ruvo M; Gioia M; Rizzarelli E; Coletta M
    J Mol Biol; 2009 Feb; 385(5):1556-67. PubMed ID: 19073193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yeast Ste23p shares functional similarities with mammalian insulin-degrading enzymes.
    Alper BJ; Rowse JW; Schmidt WK
    Yeast; 2009 Nov; 26(11):595-610. PubMed ID: 19750477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast as a tractable genetic system for functional studies of the insulin-degrading enzyme.
    Kim S; Lapham AN; Freedman CG; Reed TL; Schmidt WK
    J Biol Chem; 2005 Jul; 280(30):27481-90. PubMed ID: 15944156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme.
    Malito E; Ralat LA; Manolopoulou M; Tsay JL; Wadlington NL; Tang WJ
    Biochemistry; 2008 Dec; 47(48):12822-34. PubMed ID: 18986166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional human insulin-degrading enzyme can be expressed in bacteria.
    Chesneau V; Rosner MR
    Protein Expr Purif; 2000 Jun; 19(1):91-8. PubMed ID: 10833395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic fragments of insulysin (IDE) retain substrate binding but lose allosteric regulation.
    Song ES; Cady C; Fried MG; Hersh LB
    Biochemistry; 2006 Dec; 45(50):15085-91. PubMed ID: 17154546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme.
    Kurochkin IV
    FEBS Lett; 1998 May; 427(2):153-6. PubMed ID: 9607302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid hydroperoxide lyase in tomato fruits: cloning and properties of a recombinant enzyme expressed in Escherichia coli.
    Matsui K; Miyahara C; Wilkinson J; Hiatt B; Knauf V; Kajiwara T
    Biosci Biotechnol Biochem; 2000 Jun; 64(6):1189-96. PubMed ID: 10923789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulysin: an allosteric enzyme as a target for Alzheimer's disease.
    Song ES; Hersh LB
    J Mol Neurosci; 2005; 25(3):201-6. PubMed ID: 15800373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
    Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
    Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme.
    Manolopoulou M; Guo Q; Malito E; Schilling AB; Tang WJ
    J Biol Chem; 2009 May; 284(21):14177-88. PubMed ID: 19321446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a cDNA encoding a plant Lewis-type alpha1,4-fucosyltransferase.
    Wilson IB
    Glycoconj J; 2001 Jun; 18(6):439-47. PubMed ID: 12084979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Determinants of Substrate Specificity in Human Insulin-Degrading Enzyme.
    Stefanidis L; Fusco ND; Cooper SE; Smith-Carpenter JE; Alper BJ
    Biochemistry; 2018 Aug; 57(32):4903-4914. PubMed ID: 30004674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
    Grasso G; Rizzarelli E; Spoto G
    J Mass Spectrom; 2009 May; 44(5):735-41. PubMed ID: 19127548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AP/MALDI-MS complete characterization of the proteolytic fragments produced by the interaction of insulin degrading enzyme with bovine insulin.
    Grasso G; Rizzarelli E; Spoto G
    J Mass Spectrom; 2007 Dec; 42(12):1590-8. PubMed ID: 18085545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides.
    Kim YG; Lone AM; Nolte WM; Saghatelian A
    Proc Natl Acad Sci U S A; 2012 May; 109(22):8523-7. PubMed ID: 22586115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.
    Shen Y; Joachimiak A; Rosner MR; Tang WJ
    Nature; 2006 Oct; 443(7113):870-4. PubMed ID: 17051221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.